Baseline characteristics | n | Group | P | |
---|---|---|---|---|
IN(n = 56) | SEN(n = 56) | |||
Gender | Â | Â | Â | 0.670 |
 Male | 82 | 40(71.4%) | 42(75.0%) |  |
 Female | 30 | 16(28.6%) | 14(25.0%) |  |
Age(years) | 112 | 62.48 ± 10.207 | 60.77 ± 10.13 | 0.374 |
BMI(kg/m2) | 112 | 23.75 ± 2.73 | 23.48 ± 3.09 | 0.624 |
Hypertension | Â | Â | Â | 0.801 |
 No | 93 | 46(82.1%) | 47(83.9%) |  |
 Yes | 19 | 10(17.9%) | 9(16.1%) |  |
DM | Â | Â | Â | 0.376 |
 No | 99 | 51(88.4%) | 48(85.7%) |  |
 Yes | 13 | 5(8.9%) | 8(14.3%) |  |
ASA grade | Â | Â | Â | 0.917 |
 1 | 36 | 19(33.9%) | 17(30.4%) |  |
 2 | 64 | 31(55.4%) | 33(58.9%) |  |
 3 | 12 | 6(10.7%) | 6(10.7%) |  |
Smoke | Â | Â | Â | 0.570 |
 No | 53 | 28(50.0%) | 25(44.6%) |  |
 Yes | 59 | 28(50.0%) | 31(55.4%) |  |
Drink | Â | Â | Â | 0.118 |
 No | 70 | 39(69.6%) | 31(55.4%) |  |
 Yes | 42 | 17(30.4%) | 25(44.6%) |  |
Tumor size(cm) |  | 4.21 ± 2.319 | 4.12 ± 2.10 | 0.830 |
Differentiation of tumors | Â | Â | Â | 0.520 |
 Low | 96 | 46(82.1%) | 50(89.3%) |  |
 Middle | 14 | 9(16.1%) | 5(8.9%) |  |
 High | 2 | 1(1.8%) | 1(1.8%) |  |
T stage | Â | Â | Â | 0.071 |
 T1 | 22 | 12(21.4%) | 10(17.9%) |  |
 T2  T3 | 15 42 | 5(8.9%) 17(30.4%) | 10(17.9%) 25(44.6%) |  |
 T4 | 33 | 22(39.3%) | 11(19.6%) |  |
N stage | Â | Â | Â | 0.149 |
 N0 | 41 | 23(41.1%) | 18(32.1%) |  |
 N1 | 38 | 15(26.8%) | 23(41.1%) |  |
 N2 | 19 | 8(14.3%) | 11(19.6%) |  |
 N3 | 14 | 10(17.9%) | 4(7.1%) |  |
Surgery, n(%) | Â | Â | Â | 0.319 |
 Distal gastrectomy | 87 | 38(67.9%) | 45(80.4%) |  |
 Proximal gastrectomy | 16 | 10(17.9%) | 6(10.7%) |  |
 Total gastrectomy | 13 | 8(14.3%) | 5(8.9%) |  |
Surgical approach n(%) | Â | Â | Â | 0.327 |
 Laparoscopy | 71 | 38(67.9%) | 33(58.9%) |  |
 Robot | 41 | 18(32.1%) | 23(41.1%) |  |
HIPEC | Â | Â | Â | 0.447 |
 No | 62 | 29(51.8%) | 33(58.9%) |  |
 Yes | 50 | 27(48.2%) | 23(41.1%) |  |